Drug Profile
Filgrastim - Center of Molecular Immunology
Alternative Names: Filgrastim - CIMAB; IorLeukoCIMLatest Information Update: 12 Nov 2021
Price :
$50
*
At a glance
- Originator Center of Molecular Immunology
- Developer Center of Molecular Immunology; CIMAB
- Class Chemoprotectants; Granulocyte colony-stimulating factors; Neuroprotectants; Recombinant proteins
- Mechanism of Action Granulocyte colony stimulating factor receptor agonists; Granulocyte colony-stimulating factor replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Neutropenia
Most Recent Events
- 14 Jan 2016 Launched for Neutropenia in Cuba (SC) before January 2016 (CIMAB SA pipeline; January 2016)